Literature DB >> 14507921

Binding of anthrax toxin to its receptor is similar to alpha integrin-ligand interactions.

Kenneth A Bradley1, Jeremy Mogridge, G Jonah, A Rainey, Sarah Batty, John A T Young.   

Abstract

The secreted protein toxin produced by Bacillus anthracis contributes to virulence of this pathogen and can cause many of the symptoms seen during an anthrax infection, including shock and sudden death. The cell-binding component of anthrax toxin, protective antigen, mediates entry of the toxin into cells by first binding directly to the extracellular integrin-like inserted (I) domain of the cellular anthrax toxin receptor, ATR. Here we report that this interaction requires an intact metal ion-dependent adhesion site (MIDAS) in the receptor as well as the presence of specific divalent cations. Also, we demonstrate that the toxin-receptor interaction is critically dependent on the Asp-683 carboxylate group of protective antigen, which projects from the receptor binding surface. We propose that this carboxylate group completes the coordination of the MIDAS metal of ATR, mimicking integrin-ligand interactions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14507921     DOI: 10.1074/jbc.M307900200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation.

Authors:  D Borden Lacy; Darran J Wigelsworth; Roman A Melnyk; Stephen C Harrison; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

2.  Cytolethal distending toxin family members are differentially affected by alterations in host glycans and membrane cholesterol.

Authors:  Aria Eshraghi; Francisco J Maldonado-Arocho; Amandeep Gargi; Marissa M Cardwell; Michael G Prouty; Steven R Blanke; Kenneth A Bradley
Journal:  J Biol Chem       Date:  2010-04-12       Impact factor: 5.157

3.  Binding of filamentous actin to anthrax toxin receptor 1 decreases its association with protective antigen.

Authors:  Kristopher M Garlick; Sarah Batty; Jeremy Mogridge
Journal:  Biochemistry       Date:  2012-02-03       Impact factor: 3.162

4.  Receptor-specific requirements for anthrax toxin delivery into cells.

Authors:  G Jonah A Rainey; Darran J Wigelsworth; Patricia L Ryan; Heather M Scobie; R John Collier; John A T Young
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-01       Impact factor: 11.205

5.  Streptococcus agalactiae CAMP factor binds to GPI-anchored proteins.

Authors:  Shenhui Lang; Jie Xue; Zhongwu Guo; Michael Palmer
Journal:  Med Microbiol Immunol       Date:  2006-06-14       Impact factor: 3.402

6.  Polyvalent inhibitors of anthrax toxin that target host receptors.

Authors:  Saleem Basha; Prakash Rai; Vincent Poon; Arundhati Saraph; Kunal Gujraty; Mandy Y Go; Skanda Sadacharan; Mia Frost; Jeremy Mogridge; Ravi S Kane
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

7.  Onset of anthrax toxin pore formation.

Authors:  Mu Gao; Klaus Schulten
Journal:  Biophys J       Date:  2006-02-10       Impact factor: 4.033

8.  The cytoplasmic domain of anthrax toxin receptor 1 affects binding of the protective antigen.

Authors:  Mandy Y Go; Edith M C Chow; Jeremy Mogridge
Journal:  Infect Immun       Date:  2008-10-20       Impact factor: 3.441

9.  Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor.

Authors:  D Borden Lacy; Darran J Wigelsworth; Heather M Scobie; John A T Young; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

10.  The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin.

Authors:  Sheng Fu; Xiaohang Tong; Chenguang Cai; Ying Zhao; Yang Wu; Yuanyuan Li; Junjie Xu; Xuejun C Zhang; Long Xu; Wei Chen; Zihe Rao
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.